HOLX | tickerfilter.com

Fundamental analysis

67%

Profitability 82%

Dept financing 39%

Liquidity 51%

Performance 64%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

1.23%

1 Month

-1.54%

3 Months

11.93%

6 Months

9.61%

1 Year

6.42%

2 Year

21.25%

Key data

Stock price

$81.21

P/E Ratio

26.90

DAY RANGE

N/A - N/A

EPS

$2.91

52 WEEK RANGE

$64.02 - $84.67

52 WEEK CHANGE

$0.08

MARKET CAP

18.870 B

YIELD

N/A

SHARES OUTSTANDING

232.272 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/07/2024

BETA

0.34

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,216,007

AVERAGE 30 VOLUME

$1,562,819

Company detail

CEO: Stephen MacMillan
Region: US
Website: https://www.hologic.com/
Employees: 7,797
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

driven by our ethos, the science of sure, we’re a diverse, dedicated, creative team that develops, markets and services some of the most innovative and accurate diagnostic imaging systems and surgical products on the planet. while we’re focused and passionate about our work, we never forget that what we’re really doing is giving people greater confidence and peace of mind in their diagnosis—enabling healthier lives, everywhere, every day. connect with us at hologic.com, on facebook at facebook.com/hologicjobs, and on twitter @hologic_jobs.

HOLX - Hologic, Inc.